MedTrace Logo

Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)

NCT04518735 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1707

Last updated 2020-08-19

No results posted yet for this study

Summary

CORONA is a retrospective, observational, one center study to investigate the clinical evolution (in terms of survival and thromboembolic complications) of patients on chronic treatment with anticoagulants or antiplatelet agents who are admitted to the hospital for COVID-19 compared with patients who do not receive anticoagulants or antiplatelet agents.

Conditions

  • Covid19

Interventions

OTHER

Antithrombotic Therapy (anticoagulant and/or antiplatelet) before admission for Covid19

Review of medical records during hospitalization and until day 28 post-entry to compare the clinical outcomes depending on previous antithrombotic therapy

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04518735 on ClinicalTrials.gov